Differential Drug Resistance Acquisition in HIV-1 of Subtypes B and C

Esmeralda A. J. M. Soares, André F. A. Santos, Thatiana M. Sousa et al. · 2007

Read Differential Drug Resistance Acquisition in HIV-1 of Subtypes B and C by Esmeralda A. J. M. Soares, André F. A. Santos, Thatiana M. Sousa et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000730.txt.

Description

Esmeralda A. J. M. Soares, André F. A. Santos, Thatiana M. Sousa and colleagues compared how two HIV subtypes gain drug resistance, in PLOS ONE in 2007. Subtype C is the most prevalent HIV-1 form worldwide, dominating countries with the highest HIV rates. Few studies, though, had evaluated how antiretroviral therapy performs against it. Southern Brazil was the first developing region to offer free, universal therapy.

That setting lets the authors compare resistance acquisition in subtypes B and C under real treatment programmes. If subtypes resist differently, treatment guidelines written for subtype B may fit subtype C poorly. The comparison matters most where subtype C is common and resources are thin.

Catalog record

CREATOREsmeralda A. J. M. Soares, André F. A. Santos, Thatiana M. Sousa et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000730

Browse the full library · About the Tower of Babel